Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
are you still predicting $1?
what's your stock price prediction for next summer?
Any predictions for the end of next summer?
Nope.
robi-1, ,
Puffer's latest thinking on IV is that ALL of the material
for tox will come from the existing facility and that it will
ALL be delivered to BASi upfront. Apparently Diwan's preference
to do it that way. He thinks they will start tox by end of
next month and also thinks scale up in the existing facility
has already been accomplished. (I think there was a PR a few
months back already stating that scale up had been successfully
accomplished).
Down massively? The stock closed the night before the PT
article at $4.42. It closed today at $4.29. Trying to
characterize 3% as massive is a bit laughable. You might
consult a chart next time before rushing to the keyboard.
I think this probably explains it,
foxes are harder to come by and they are very unruly. Also, fox studies take a lot longer than other animal studies.
no, it's important to raise non-pertinent issues about a
company 18 hrs a day, 7 days a week.
I guess you are unaware of the 6 month restriction from date of
exercise. So much for another bogus theory.
Wow, really?
No, they don't have to do tox on each strain of the flu, just efficacy testing.
And no, BASi is in Indiana which is quite some distance from Australia.
you are forgetting that the short interest started over at
zero with the switch to the new exchange.
I guess this is your first rodeo with small biotechs. 7% is a rather
smallish short interest, well below average.
that's not what I was referring to. I was talking about this statement that referred to it as being essentially a short sale,
that is a complete mischaracterization. The stock sold by Diwan in Oct
of '13 is essentially what he purchased in Feb of the same year. He took advantage of a large move in the stock that had occurred since his purchase. He bought back in Feb of this year to show support after the Seeking Alpha hit piece.
7% short interest is nothing for a small biotech. Well below the average.
Oh no, you just paved the way for the next red herring.
I thought you just said a couple of days ago you were buying at $4.50???
?? After the initial open on a few shares it never traded back to
$4.50.
noooo its going to 2 clams by the end of the summer, remember???
Or was that 1 clam??? LOL